How Do Cannabinoid Receptors Affect Motivation to Eat or Exercise?

Physical inactivity is a common factor in lifestyle diseases – and one that is often linked to the excessive consumption of fatty and/or sugary foods. The opposite scenario of excessive physical activity at the expense of caloric intake can also be harmful, as cases of anorexia nervosa illustrate. These scenariosRead …

Read moreHow Do Cannabinoid Receptors Affect Motivation to Eat or Exercise?

Omega-3 Fatty Acids Reduce Inflammation through Cannabinoids

Omega-3
The chemical compounds called cannabinoids, found in cannabis and hemp, are also produced naturally in the body from omega-3 fatty acids. A new study in animal tissue reveals the cascade of chemical reactions that convert omega-3 fatty acids into cannabinoids that have anti-inflammatory benefits. The findings are published in the

Read moreOmega-3 Fatty Acids Reduce Inflammation through Cannabinoids

Cannabidiol May Reduce Intestinal Inflammation

Legal Cannabis

In this study, published in PLOS ONE, researchers explored the role of cannabidiol for intestinal inflammation. This research looked enteric glial cells (EGC), which plays a fundamental role in the maintenance of gut homeostasis. They assure the correct trophism of vicinal neurons in the myenteric plexus and actively participate inRead …

Read moreCannabidiol May Reduce Intestinal Inflammation

Is the New York Times Picking on the Science for CBD?

A recent New York Times article, CBD is Everywhere, But Scientists Still Don’t Know Much About It, paints a picture of snake-oil sales, hyped-up claims and minuscule science. Is that true or a journalistic stretch? The article prompted Today’s Practitioner to dig up two well-researched studies from Cannabis and CannabinoidRead …

Read moreIs the New York Times Picking on the Science for CBD?

Understanding Cannabinoid Delivery Systems and Clinical Applications

There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressing

Read moreUnderstanding Cannabinoid Delivery Systems and Clinical Applications

The Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases

Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system, caused by an autoimmune response against myelin that eventually leads to progressive neurodegeneration and disability. Although the knowledge on its underlying neurobiological mechanisms has considerably improved, there is a still unmet need for new treatment options,

Read moreThe Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases

Is Cannabidiol the Next Clinical Antioxidant?

Cannabidiol as an antioxidant

Emerging research shows that cannabidiol holds unique properties as an antioxidant. In the scientific summary, we profile two studies that review the potential of non-psychotropic cannabidiol as an antioxidant. This research has future clinical implications for cerebral ischemia, rheumatoid arthritis, types I and II diabetes, atherosclerosis, Alzheimer’s disease, hypertension, theRead …

Read moreIs Cannabidiol the Next Clinical Antioxidant?

Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients

Prescription CBD for Epilepsy

Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term forRead …

Read moreEffectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients

Derrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand

CBD for Common Conditions, Dr. DeSilva

In this video, Dr. DeSilva shares some case studies and how he is prescribing CBD for common conditions for his patients. In this video series he discusses the following: Case studies of patient response to CBD for sleep and auto-immunity, Researching the right brand of CBD, What to look forRead …

Read moreDerrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand

New Pathways Discovered for CBD’s Ability to Provide Pain and Anxiety Relief

pain and anxiety

While cannabidiol (CBD) is fast becoming a common compound for pain and anxiety relief, the exact pathways and dosage have remained elusive. A recent study, published in the journal PAIN, identified new pathways, beyond the endocannabinoid system, which explain its analgesic and anti-anxiety benefits. They are surprisingly different than whatRead …

Read moreNew Pathways Discovered for CBD’s Ability to Provide Pain and Anxiety Relief